LifeCuff Technologies, Inc. is developing a patented technology platform for automating and personalizing the RIC process in addressing multiple indications.  Resulting products will improve outcomes by delivering the therapy effectively.  Two noninvasive electronic medical devices are  in development: the HomeCuff and LifeCuff Devices.

The HomeCuff Device will Enable Extended Use

 
image003 (1).jpg
 

The HomeCuff Device will initially target two indications that require iterative therapy and that are supported by positive studies of manually delivered RIC.  The first will be chronic diabetic wounds and the second, preventing second strokes.   It is expected to save considerable time and money for patients, physicians and insurance companies.

Where Used.  The HomeCuff Device is being developed for use as an adjunct to standard of care by patients at home under a physician’s supervision. Because the device will be convenient and easy to use, it will have the potential to make RIC delivery ultimately ubiquitous for home use.

How It Works. The HomeCuff Device will be non-invasive, portable and automated and will plug into an outlet.  A single cuff will deliver ischemic conditioning, display vital signs and contain its power source.  Of special importance is the fact that the device has been designed for use on virtually all patients regardless of their blood pressure levels. It  will self-adjust cuff pressure to the best patient comfort level and offer 100 percent efficacious pressure levels.  It will also be possible to upgrade the device if the protocol or procedure changes. 

Benefits for Patients.   Healing where none was possible.  Rapid healing.  Less pain with no side effects.  And the device will be reimbursable. 

The Disposable LifeCuff Device will Treat Acute Indications

The LifeCuff Device will target two indications that require treatment before or during an acute event and that are supported by positive studies of manually delivered RIC - to reduce post-heart-attack heart failures and reduce post-orthopedic surgery pain and opioid use.  The device’s technology will combine automated delivery of RIC with vital signs monitoring in a single blood pressure cuff.

Where Used.  LifeCuff has been designed for use as an adjunct to standard of care across the spectrum of care: in acute care settings, including the ambulance or emergency room or before Cath Lab procedures or other cardiac interventions, in hospitals and other medical centers, and in physician’s offices.  Because the device will be so convenient and easy to use, it has the potential to make RIC delivery ultimately ubiquitous.

How It Works.  The all-in-one design, with no assembly required, is one factor in convenience for healthcare professionals at a time when emergency or acute care is needed.  The other convenience factor, disposability, avoids the risk of hospital-caused infections. 

LifeCuff will be non-invasive, portable and automated.  A single cuff will deliver ischemic conditioning, display vital signs, and contain its power source.  Of special importance is the fact that the device has been designed for use on virtually all patients regardless of their blood pressure levels. The device will self-adjust cuff pressure to the best patient comfort level and offer 100 percent efficacious pressure levels.  It will also be possible to upgrade the device if the protocol or procedure changes. 

Benefits for Patients.   Healing where none was possible.  Rapid healing.  Less pain with no side effects.  And the device will be reimbursable. 

 

ESTIMATED MARKET STATISTICS

 
 
Screen Shot 2019-04-04 at 1.23.01 PM.png
 
 

This Market will Grow with

the Aging of America

 
Screen Shot 2019-04-04 at 1.24.04 PM.png